Intraoperative ketorolac may interact with patient-specific tumour genomics to modify recurrence risk in lung adenocarcinoma: an exploratory analysis

Br J Anaesth. 2021 Sep;127(3):e82-e85. doi: 10.1016/j.bja.2021.05.032. Epub 2021 Jul 14.

¹ Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Department of Anesthesiology, Weill Cornell Medicine, New York, NY, USA.
³ Dana-Farber Brigham and Women's Cancer Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.
⁴ Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁵ Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁶ Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁷ Department of Anesthesiology, Weill Cornell Medicine, New York, NY, USA; Department of Anesthesiology & Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁸ Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: [email protected].
⁹ Department of Anesthesiology, Weill Cornell Medicine, New York, NY, USA; Department of Anesthesiology & Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: [email protected].

No abstract available

Keywords: RNA sequencing; ketorolac; lung adenocarcinoma; next-generation sequencing; recurrence.

Publication types